Anand C. Burman

Dr. Anand C. Burman, Chairman of Dabur India Limited, is an eminent industrialist with particular interests in the areas of research & development in pharmaceutical sciences and biotechnology. He is technology savvy and a keen follower of the latest developments in the technology arena.

Dr. Burman holds a bachelor's degree in chemistry from the University of Wisconsin; an M.Sc. in chemistry and a doctorate in the area of pharmaceutical chemistry from the University of Kansas.

Professionally, he has held many assignments with Dabur Group since 1980, starting with the R&D division of the Company. He is currently the Chairman of Dabur India Limited and serves as director on the Board of Dabur Research Foundation; H & B Stores Limited; Dabur (UK) Limited, UK; Dabur International Limited, UAE; Hobi Kozmetik, Turkey; Dermoviva Skin Essentials Inc., USA; amongst others.

Other than the Dabur Group Companies, he is also on the Board of Aviva Life Insurance, Hindustan Motors Limited, Hero MotoCorp Limited, Ester Industries Limited, etc.

In addition, he is a member of the Advisory Board of the Institute for Advancing Medical Innovation under the University of Kansas, USA.

Dabur India Limited is the fourth largest fast moving consumer goods (FMCG) company in India with revenues of US$910 million (Rs 4110 Crore) & market capitalisation of US$4 billion (Rs 20,000 Crore). Dabur India is a world leader in Ayurveda with a portfolio of over 250 Herbal/Ayurvedic products. Dabur's FMCG portfolio today includes five flagship brands with distinct brand identities -- Dabur as the master brand for natural healthcare products, Vatika for premium personal care, Hajmola for digestives, Réal for fruit juices and beverages and Fem for fairness bleaches and skin care products. Dabur's products are also available in over 60 countries across the globe. Its brands are in the Middle East, Africa, SAARC countries, the US, Europe and Russia. Dabur's overseas revenues account for over 20% of the total turnover.